Conventional disease-modifying antirheumatic drugs therapy may not slow spinal radiographic progression in ankylosing spondylitis: results from an 18-year longitudinal dataset

OBJECTIVES: The clinical benefit of conventional disease-modifying antirheumatic drugs (cDMARDs) for treating ankylosing spondylitis (AS) is generally limited to improvements in peripheral arthritis. However, cDMARDs could be conditionally considered as alternatives to established drugs for improvin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Tae-Han, Koo, Bon San, Nam, Bora, Oh, Ji Seon, Park, Seo Young, Lee, Seunghun, Joo, Kyung Bin, Kim, Tae-Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705797/
https://www.ncbi.nlm.nih.gov/pubmed/33294039
http://dx.doi.org/10.1177/1759720X20975912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705797/
https://www.ncbi.nlm.nih.gov/pubmed/33294039
http://dx.doi.org/10.1177/1759720X20975912

Ejemplares similares